Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta‐analysis

An increasing amount of evidence has emerged suggesting that hidradenitis suppurativa (HS) is associated with inflammatory arthritis. This study reviewed the incidence, prevalence, and predictors of inflammatory arthritis in patients with HS. A comprehensive literature search was conducted in CINAHL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of dermatology 2022-09, Vol.61 (9), p.1069-1079
Hauptverfasser: Hanna, Nardin, Silverberg, Orli M., Reaume, Michael, Gladman, Dafna, Davis, Mark D. P., Piguet, Vincent, Alavi, Afsaneh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1079
container_issue 9
container_start_page 1069
container_title International journal of dermatology
container_volume 61
creator Hanna, Nardin
Silverberg, Orli M.
Reaume, Michael
Gladman, Dafna
Davis, Mark D. P.
Piguet, Vincent
Alavi, Afsaneh
description An increasing amount of evidence has emerged suggesting that hidradenitis suppurativa (HS) is associated with inflammatory arthritis. This study reviewed the incidence, prevalence, and predictors of inflammatory arthritis in patients with HS. A comprehensive literature search was conducted in CINAHL, Embase, and Medline from inception to February 14, 2020. Articles were included in the review if they provided data on disease epidemiology or predictors of adult or pediatric HS patients with comorbid inflammatory arthritis. There are no validated diagnostic criteria for HS, thus we considered patients as having HS if they had at least one diagnostic code in a hospital or claims database or a diagnosis of HS/inflammatory arthritis in a medical record. The same criteria were used to confirm presence of inflammatory arthritis. We identified an increased incidence of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) in HS patients when compared with estimates in the general population. We identified a relatively high prevalence of RA, spondyloarthritis (SpA), and PsA in HS patients when compared with estimates in the general population. There was evidence to suggest that patients who are younger than 30, male, have severe HS, or are taking infliximab or adalimumab (which may also be confounded by HS disease severity) may be at greater risk for specific subtypes of inflammatory arthritis. However, further data are needed to confirm these associations. The increased incidence and prevalence of inflammatory arthritis within HS patients underscore the need for increased awareness and interdisciplinary partnership within rheumatology and dermatology.
doi_str_mv 10.1111/ijd.15860
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2564488461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2564488461</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3300-44ae989683a355a835e08511632e7f0959213eb10b5589219b81aee133145a433</originalsourceid><addsrcrecordid>eNp1kUtO5DAQhi00SPQAC25gic2MRMBu28GZ3YhnIyQ2sI6qk4rarbzGdmhlxxEQR-QkFJ1ZIeGN63d99bB-xo6kOJV0zty6PJXGpmKHzaRKTaJTNf_BZkJImWTCZHvsZwhrkmou9Yy9LdrCldgWeMJ7j89QTzG05acuXRE7H3hXcddWNTQNkB45-LjyLrpAz7yH6LCNgW9cXPGVKz1Qx202DH0_eMo_wx8OPIwhIrVwBadZDjfbOQ1GeH95hRbqMbhwwHYrqAMe_r_32dP11ePFbXL_cLO4-HufFEoJkWgNmNkstQqUMWCVQWGNlPRfPK9EZrK5VLiUYmmMpThbWgmIUimpDWil9tmvqW_vu38Dhpg3LhRY19BiN4R8blKtrdWpJPT4C7ruBk_7EnUuFK2htSDq90QVvgvBY5X33jXgx1yK_NOdnNzJt-4QezaxG1fj-D2YL-4up4oPwp6TBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2703989440</pqid></control><display><type>article</type><title>Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta‐analysis</title><source>Wiley-Blackwell Journals</source><creator>Hanna, Nardin ; Silverberg, Orli M. ; Reaume, Michael ; Gladman, Dafna ; Davis, Mark D. P. ; Piguet, Vincent ; Alavi, Afsaneh</creator><creatorcontrib>Hanna, Nardin ; Silverberg, Orli M. ; Reaume, Michael ; Gladman, Dafna ; Davis, Mark D. P. ; Piguet, Vincent ; Alavi, Afsaneh</creatorcontrib><description>An increasing amount of evidence has emerged suggesting that hidradenitis suppurativa (HS) is associated with inflammatory arthritis. This study reviewed the incidence, prevalence, and predictors of inflammatory arthritis in patients with HS. A comprehensive literature search was conducted in CINAHL, Embase, and Medline from inception to February 14, 2020. Articles were included in the review if they provided data on disease epidemiology or predictors of adult or pediatric HS patients with comorbid inflammatory arthritis. There are no validated diagnostic criteria for HS, thus we considered patients as having HS if they had at least one diagnostic code in a hospital or claims database or a diagnosis of HS/inflammatory arthritis in a medical record. The same criteria were used to confirm presence of inflammatory arthritis. We identified an increased incidence of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) in HS patients when compared with estimates in the general population. We identified a relatively high prevalence of RA, spondyloarthritis (SpA), and PsA in HS patients when compared with estimates in the general population. There was evidence to suggest that patients who are younger than 30, male, have severe HS, or are taking infliximab or adalimumab (which may also be confounded by HS disease severity) may be at greater risk for specific subtypes of inflammatory arthritis. However, further data are needed to confirm these associations. The increased incidence and prevalence of inflammatory arthritis within HS patients underscore the need for increased awareness and interdisciplinary partnership within rheumatology and dermatology.</description><identifier>ISSN: 0011-9059</identifier><identifier>EISSN: 1365-4632</identifier><identifier>DOI: 10.1111/ijd.15860</identifier><language>eng</language><publisher>Hoboken: Blackwell Publishing Ltd</publisher><subject>Ankylosing spondylitis ; Arthritis ; Criteria ; Dermatology ; Diagnostic systems ; Epidemiology ; Estimates ; Inflammation ; Inflammatory diseases ; Infliximab ; Meta-analysis ; Monoclonal antibodies ; Patients ; Pediatrics ; Psoriatic arthritis ; Rheumatic diseases ; Rheumatoid arthritis ; Rheumatology ; Tumor necrosis factor-α</subject><ispartof>International journal of dermatology, 2022-09, Vol.61 (9), p.1069-1079</ispartof><rights>2021</rights><rights>International Journal of Dermatology © 2022 International Society of Dermatology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3300-44ae989683a355a835e08511632e7f0959213eb10b5589219b81aee133145a433</citedby><cites>FETCH-LOGICAL-c3300-44ae989683a355a835e08511632e7f0959213eb10b5589219b81aee133145a433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijd.15860$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijd.15860$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Hanna, Nardin</creatorcontrib><creatorcontrib>Silverberg, Orli M.</creatorcontrib><creatorcontrib>Reaume, Michael</creatorcontrib><creatorcontrib>Gladman, Dafna</creatorcontrib><creatorcontrib>Davis, Mark D. P.</creatorcontrib><creatorcontrib>Piguet, Vincent</creatorcontrib><creatorcontrib>Alavi, Afsaneh</creatorcontrib><title>Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta‐analysis</title><title>International journal of dermatology</title><description>An increasing amount of evidence has emerged suggesting that hidradenitis suppurativa (HS) is associated with inflammatory arthritis. This study reviewed the incidence, prevalence, and predictors of inflammatory arthritis in patients with HS. A comprehensive literature search was conducted in CINAHL, Embase, and Medline from inception to February 14, 2020. Articles were included in the review if they provided data on disease epidemiology or predictors of adult or pediatric HS patients with comorbid inflammatory arthritis. There are no validated diagnostic criteria for HS, thus we considered patients as having HS if they had at least one diagnostic code in a hospital or claims database or a diagnosis of HS/inflammatory arthritis in a medical record. The same criteria were used to confirm presence of inflammatory arthritis. We identified an increased incidence of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) in HS patients when compared with estimates in the general population. We identified a relatively high prevalence of RA, spondyloarthritis (SpA), and PsA in HS patients when compared with estimates in the general population. There was evidence to suggest that patients who are younger than 30, male, have severe HS, or are taking infliximab or adalimumab (which may also be confounded by HS disease severity) may be at greater risk for specific subtypes of inflammatory arthritis. However, further data are needed to confirm these associations. The increased incidence and prevalence of inflammatory arthritis within HS patients underscore the need for increased awareness and interdisciplinary partnership within rheumatology and dermatology.</description><subject>Ankylosing spondylitis</subject><subject>Arthritis</subject><subject>Criteria</subject><subject>Dermatology</subject><subject>Diagnostic systems</subject><subject>Epidemiology</subject><subject>Estimates</subject><subject>Inflammation</subject><subject>Inflammatory diseases</subject><subject>Infliximab</subject><subject>Meta-analysis</subject><subject>Monoclonal antibodies</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Psoriatic arthritis</subject><subject>Rheumatic diseases</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatology</subject><subject>Tumor necrosis factor-α</subject><issn>0011-9059</issn><issn>1365-4632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp1kUtO5DAQhi00SPQAC25gic2MRMBu28GZ3YhnIyQ2sI6qk4rarbzGdmhlxxEQR-QkFJ1ZIeGN63d99bB-xo6kOJV0zty6PJXGpmKHzaRKTaJTNf_BZkJImWTCZHvsZwhrkmou9Yy9LdrCldgWeMJ7j89QTzG05acuXRE7H3hXcddWNTQNkB45-LjyLrpAz7yH6LCNgW9cXPGVKz1Qx202DH0_eMo_wx8OPIwhIrVwBadZDjfbOQ1GeH95hRbqMbhwwHYrqAMe_r_32dP11ePFbXL_cLO4-HufFEoJkWgNmNkstQqUMWCVQWGNlPRfPK9EZrK5VLiUYmmMpThbWgmIUimpDWil9tmvqW_vu38Dhpg3LhRY19BiN4R8blKtrdWpJPT4C7ruBk_7EnUuFK2htSDq90QVvgvBY5X33jXgx1yK_NOdnNzJt-4QezaxG1fj-D2YL-4up4oPwp6TBA</recordid><startdate>202209</startdate><enddate>202209</enddate><creator>Hanna, Nardin</creator><creator>Silverberg, Orli M.</creator><creator>Reaume, Michael</creator><creator>Gladman, Dafna</creator><creator>Davis, Mark D. P.</creator><creator>Piguet, Vincent</creator><creator>Alavi, Afsaneh</creator><general>Blackwell Publishing Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202209</creationdate><title>Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta‐analysis</title><author>Hanna, Nardin ; Silverberg, Orli M. ; Reaume, Michael ; Gladman, Dafna ; Davis, Mark D. P. ; Piguet, Vincent ; Alavi, Afsaneh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3300-44ae989683a355a835e08511632e7f0959213eb10b5589219b81aee133145a433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Ankylosing spondylitis</topic><topic>Arthritis</topic><topic>Criteria</topic><topic>Dermatology</topic><topic>Diagnostic systems</topic><topic>Epidemiology</topic><topic>Estimates</topic><topic>Inflammation</topic><topic>Inflammatory diseases</topic><topic>Infliximab</topic><topic>Meta-analysis</topic><topic>Monoclonal antibodies</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Psoriatic arthritis</topic><topic>Rheumatic diseases</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatology</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hanna, Nardin</creatorcontrib><creatorcontrib>Silverberg, Orli M.</creatorcontrib><creatorcontrib>Reaume, Michael</creatorcontrib><creatorcontrib>Gladman, Dafna</creatorcontrib><creatorcontrib>Davis, Mark D. P.</creatorcontrib><creatorcontrib>Piguet, Vincent</creatorcontrib><creatorcontrib>Alavi, Afsaneh</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hanna, Nardin</au><au>Silverberg, Orli M.</au><au>Reaume, Michael</au><au>Gladman, Dafna</au><au>Davis, Mark D. P.</au><au>Piguet, Vincent</au><au>Alavi, Afsaneh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta‐analysis</atitle><jtitle>International journal of dermatology</jtitle><date>2022-09</date><risdate>2022</risdate><volume>61</volume><issue>9</issue><spage>1069</spage><epage>1079</epage><pages>1069-1079</pages><issn>0011-9059</issn><eissn>1365-4632</eissn><abstract>An increasing amount of evidence has emerged suggesting that hidradenitis suppurativa (HS) is associated with inflammatory arthritis. This study reviewed the incidence, prevalence, and predictors of inflammatory arthritis in patients with HS. A comprehensive literature search was conducted in CINAHL, Embase, and Medline from inception to February 14, 2020. Articles were included in the review if they provided data on disease epidemiology or predictors of adult or pediatric HS patients with comorbid inflammatory arthritis. There are no validated diagnostic criteria for HS, thus we considered patients as having HS if they had at least one diagnostic code in a hospital or claims database or a diagnosis of HS/inflammatory arthritis in a medical record. The same criteria were used to confirm presence of inflammatory arthritis. We identified an increased incidence of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriatic arthritis (PsA) in HS patients when compared with estimates in the general population. We identified a relatively high prevalence of RA, spondyloarthritis (SpA), and PsA in HS patients when compared with estimates in the general population. There was evidence to suggest that patients who are younger than 30, male, have severe HS, or are taking infliximab or adalimumab (which may also be confounded by HS disease severity) may be at greater risk for specific subtypes of inflammatory arthritis. However, further data are needed to confirm these associations. The increased incidence and prevalence of inflammatory arthritis within HS patients underscore the need for increased awareness and interdisciplinary partnership within rheumatology and dermatology.</abstract><cop>Hoboken</cop><pub>Blackwell Publishing Ltd</pub><doi>10.1111/ijd.15860</doi><tpages>1079</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0011-9059
ispartof International journal of dermatology, 2022-09, Vol.61 (9), p.1069-1079
issn 0011-9059
1365-4632
language eng
recordid cdi_proquest_miscellaneous_2564488461
source Wiley-Blackwell Journals
subjects Ankylosing spondylitis
Arthritis
Criteria
Dermatology
Diagnostic systems
Epidemiology
Estimates
Inflammation
Inflammatory diseases
Infliximab
Meta-analysis
Monoclonal antibodies
Patients
Pediatrics
Psoriatic arthritis
Rheumatic diseases
Rheumatoid arthritis
Rheumatology
Tumor necrosis factor-α
title Incidence, prevalence, and predictors of inflammatory arthritis in patients with hidradenitis suppurativa: a systematic review and meta‐analysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence,%20prevalence,%20and%20predictors%20of%20inflammatory%20arthritis%20in%20patients%20with%20hidradenitis%20suppurativa:%20a%20systematic%20review%20and%20meta%E2%80%90analysis&rft.jtitle=International%20journal%20of%20dermatology&rft.au=Hanna,%20Nardin&rft.date=2022-09&rft.volume=61&rft.issue=9&rft.spage=1069&rft.epage=1079&rft.pages=1069-1079&rft.issn=0011-9059&rft.eissn=1365-4632&rft_id=info:doi/10.1111/ijd.15860&rft_dat=%3Cproquest_cross%3E2564488461%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2703989440&rft_id=info:pmid/&rfr_iscdi=true